Literature DB >> 18572022

Persistent susceptibility of cathepsin B to irreversible inhibition by nitroxyl (HNO) in the presence of endogenous nitric oxide.

Antti J Väänänen1, Pertteli Salmenperä, Mika Hukkanen, Katrina M Miranda, Ari Harjula, Pekka Rauhala, Esko Kankuri.   

Abstract

Nitrosation of enzyme regulatory cysteines is one of the key posttranslational modification mechanisms of enzyme function. Frequently such modifications are readily reversible; however, cysteine proteases, such as cathepsin B, have been shown to be covalently and permanently inactivated by nitroxyl (HNO), the one-electron reduction product of NO. Owing to the high reactivity of HNO with NO, endogenous NO production could provide direct protection for the less reactive protein cysteines by scavenging HNO. Additionally, endogenous cellular production of NO could rescue enzyme function by protective nitrosation of cysteines prior to exposure to HNO. Thus, we studied the effect of endogenous NO production, induced by LPS or IFN-gamma, on inhibition of cysteine protease cathepsin B in RAW macrophages. Both LPS and IFN-gamma induce iNOS with generation of nitrate up to 9 muM in the media after a 24-h stimulation, while native RAW 264.7 macrophages neither express iNOS nor generate nitrate. After the 24-h stimulation, the HNO-releasing Angeli's salt (0-316 microM) caused dose-dependent and DTT-irreversible loss of cathepsin B activity, and induction of iNOS activity did not protect the enzyme. The lack of protection was also verified in an in vitro setup, where papain, a close structural analogue of cathepsin B, was inhibited by Angeli's salt (2.7 microM) in the presence of the NO donor DEA/NO (0-316 microM). This clearly showed that a high molar excess of DEA/NO (EC(50) 406 microM) is needed to protect papain from the DTT-irreversible covalent modification by HNO. Our results provide first evidence on a cellular level for the remarkably high sensitivity of active-site cysteines in cysteine proteases for modification by HNO.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18572022     DOI: 10.1016/j.freeradbiomed.2008.05.025

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

Review 1.  The emergence of nitroxyl (HNO) as a pharmacological agent.

Authors:  Christopher H Switzer; Wilmarie Flores-Santana; Daniele Mancardi; Sonia Donzelli; Debashree Basudhar; Lisa A Ridnour; Katrina M Miranda; Jon M Fukuto; Nazareno Paolocci; David A Wink
Journal:  Biochim Biophys Acta       Date:  2009-05-06

Review 2.  The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.

Authors:  Wilmarie Flores-Santana; Debra J Salmon; Sonia Donzelli; Christopher H Switzer; Debashree Basudhar; Lisa Ridnour; Robert Cheng; Sharon A Glynn; Nazareno Paolocci; Jon M Fukuto; Katrina M Miranda; David A Wink
Journal:  Antioxid Redox Signal       Date:  2011-03-16       Impact factor: 8.401

3.  Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors.

Authors:  Gail M Johnson; Tyler J Chozinski; Elyssia S Gallagher; Craig A Aspinwall; Katrina M Miranda
Journal:  Free Radic Biol Med       Date:  2014-07-23       Impact factor: 7.376

4.  Nitroxyl (HNO) acutely activates the glucose uptake activity of GLUT1.

Authors:  Matthew J Salie; Daniel S Oram; David P Kuipers; Jared P Scripture; Jude Chenge; Griffin J MacDonald; Larry L Louters
Journal:  Biochimie       Date:  2011-12-11       Impact factor: 4.079

5.  Hydroxylamine acutely activates glucose uptake in L929 fibroblast cells.

Authors:  Larry L Louters; Jared P Scripture; David P Kuipers; Stephen M Gunnink; Benjamin D Kuiper; Ola D Alabi
Journal:  Biochimie       Date:  2012-11-27       Impact factor: 4.079

6.  The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols.

Authors:  Thomas W Miller; Melisa M Cherney; Andrea J Lee; Nestor E Francoleon; Patrick J Farmer; S Bruce King; Adrian J Hobbs; Katrina M Miranda; Judith N Burstyn; Jon M Fukuto
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

Review 7.  Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties.

Authors:  Mai E Shoman; Omar M Aly
Journal:  Oxid Med Cell Longev       Date:  2015-12-07       Impact factor: 6.543

8.  Endothelial pulsatile shear stress is a backstop for COVID-19.

Authors:  Marvin A Sackner; Jose A Adams
Journal:  Emerg Top Life Sci       Date:  2020-12-11

9.  Kinetics of Azanone (HNO) Reactions with Thiols: Effect of pH.

Authors:  Renata Smulik-Izydorczyk; Karolina Dębowska; Michał Rostkowski; Jan Adamus; Radosław Michalski; Adam Sikora
Journal:  Cell Biochem Biophys       Date:  2021-05-05       Impact factor: 2.194

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.